RICHARDSON, Texas, April 19 /PRNewswire/ -- Zyvex today announced financial results for its fiscal 2006 first quarter. The Texas company continues its business gains with total revenues for the quarter totaling $2,956,582 -- a 45 percent increase over the same period in 2005. "Our first quarter exceeded expectations," said Zyvex CFO Timothy M. Gilmore. "These financial results are a direct effect of our consistent execution to our strategic plan and our continued goal of delivering value to our customers." "We are totally committed to long-term product innovation and customer value," said Zyvex President Dr. Thomas A. Cellucci. "Our financial successes over the past five years are a reflection of our strong IP position and our customer's loyalty and passion for our products' value, quality, and performance." This month, Zyvex also introduced its L200 Nanomanipulator for the Life Science arena. Researchers can use the L200 for cellular manipulation, biomaterials characterization, patch-clamping, micro-injection, and intra- and extra cellular probing. The company also released the F100-TSP Nanomanipulator for TEM Sample Lift-out. Founded in 1997, Zyvex reported its first revenues in 2001, grossing $150,000. Company revenues grew to $1.2 Million in 2002, $4.3 Million in 2003, $8.6 Million in 2004, and $10.3 Million in 2005. The Zyvex team anticipates that the company will achieve cash-flow break-even during 2006. The company has an impressive patent portfolio with 32 U.S. Patents (with another 32 pending), and 6 International Patents (with another 52 pending). Zyvex has customers in the Aerospace/Defense, Healthcare/Medical, and Electronics/Semiconductor industries. Zyvex has numerous key alliances with industry leaders, including Easton Sports, Frost & Sullivan, MIT's Institute for Soldier Nanotechnologies, and Texas Instruments. Zyvex has worldwide sales representation in Australia, China, France, Germany, Italy, Japan, Korea, Malaysia, New Zealand, Poland, Singapore, Spain, Switzerland, Taiwan, Thailand, the United Kingdom, and Vietnam through alliances with Keithley Instruments, Inc., Caltron, Pte., Coherent Scientific Pty Ltd., and L.O.T.-Oriel. About the Company Zyvex Corporation, based in Richardson, Texas, is the first molecular nanotechnology company. Zyvex's vision is to be the leading worldwide supplier of tools, products, and services that enable adaptable, affordable, and molecularly precise manufacturing. Zyvex commercializes nanotechnology to address real-world applications with high growth potential. Zyvex carries its scientific breakthroughs into key commercial applications in the area of materials, tools, and structures.
SOURCE Zyvex Corporation